Molecular Crosstalk between Cancer Stem Cells and the Tumor Microenvironment: Therapeutic Implications

Abstract

The dynamic interaction between cancer stem cells (CSCs) and the tumor microenvironment (TME) is increasingly recognized as a key driver of tumor progression, metastasis, and therapeutic resistance. Disrupting this molecular crosstalk offers a promising strategy to improve cancer treatment outcomes. Exosomes derived from CSCs mediate critical communication with TME, promoting tumor progression by enhancing CSC stemness, inducing angiogenesis, facilitating metastasis, and modulating immune responses to create an immunosuppressive milieu. Recent advances highlight the potential of targeting the supportive CSC niche, modulating immune responses, and inhibiting exosome-mediated signaling to eradicate CSCs and overcome resistance. Innovative approaches including precision stem cell therapies, personalized treatment strategies based on TME characteristics, and the use of 3D tumor models and organoids are paving the way for more effective and individualized therapies. Integrating immunotherapy with CSC-targeted interventions may further enhance clinical efficacy. Continued research into CSC- TME interactions is vital for translating these insights into transformative cancer treatments.